Natalie Sacks is Chief Medical Officer of Harpoon Therapeutics Inc.
Person profile
Roles
Address
Berkeley, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Caribou Biosciences, Inc.
23 Feb 23
4
Zymeworks Inc.
23 Dec 22
4
Harpoon Therapeutics, Inc.
1 Feb 22
4
Caribou Biosciences, Inc.
21 Dec 21
4
Harpoon Therapeutics, Inc.
15 Nov 21
3
Caribou Biosciences, Inc.
22 Jul 21
4
Zymeworks Inc.
7 May 21
4
Harpoon Therapeutics, Inc.
29 Jan 21
4
Harpoon Therapeutics, Inc.
20 May 20
4
Zymeworks Inc.
12 May 20
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Feb 23 | CRBU Caribou Biosciences | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 6.12 | 21,500 | 131.58 k | 21,500 |
| 21 Dec 22 | ZYME Zymeworks | Stock Option Common Stock | Grant | Acquire A | No | No | 8.75 | 25,000 | 218.75 k | 25,000 |
| 28 Jan 22 | HARP Harpoon Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 5.03 | 155,000 | 779.65 k | 155,000 |
| 20 Dec 21 | CRBU Caribou Biosciences | Option to purchase Common Stock Common Stock | Grant | Acquire A | No | No | 15.16 | 27,500 | 416.90 k | 27,500 |
| 11 Nov 21 | HARP Harpoon Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 7.73 | 155,000 | 1.20 mm | 155,000 |